Company / Revenue per Share
LEXICON PHARMACEUTICALS, INC. Revenue per Share History
FY2013-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.00
FY2025
5-year range
$0.00 / $0.76
FY2021-FY2025
Trend
+295.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue per Share changed +295% YoY in FY2025, a notable deviation from the 9-year average annual change of +271%.
Based on SEC 10-K filings.
0.00 in FY2025 with a 10-year CAGR of -19.8%.
Improved from $0.00 to $0.00 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -19.8%
Key checks
Key Insights
- In FY2025, revenue per share increased 295.4% year-over-year.
- Peak revenue per share was recorded in FY2017.
- Lowest revenue per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -1.98 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.00 | +295.4% |
| FY2024 | $0.00 | -59.0% |
| FY2023 | $0.00 | -99.1% |
| FY2019 | $0.23 | -70.2% |
| FY2018 | $0.76 | -39.2% |
| FY2017 | $1.26 | +319.3% |
| FY2016 | $0.30 | +887.5% |
| FY2015 | $0.03 | +1263.1% |
| FY2014 | $0.00 | -59.0% |
| FY2013 | $0.01 | -66.5% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026